Interestingly, L290P/V mutations of ERK3 that are identified in some cancers, albeit at a low frequency, cause an increase in cytosolic localization of ERK3 and enhanced ability to promote migration and invasion in lung cancer cell lines [53]. Here, MAPK6 is linked to cancer.